| ||||||||||||||
|
|
|||||||||||||
Department of Anesthesiology, American University of Beirut, Beirut-Lebanon
Address correspondence and reprint requests to Anis Baraka, MD, FRCA, Professor and Chairman, Department of Anesthesiology, American University of Beirut, PO Box 113-6044, Beirut-Lebanon. Address e-mail to abaraka{at}aub.edu.lb
We investigated the incidence of transient neurologic symptoms (TNS) after the use of hyperbaric lidocaine as compared with hyperbaric bupivacaine in patients undergoing cesarean delivery under spinal anesthesia. Two hundred women scheduled for cesarean delivery were randomly allocated to receive spinal anesthesia with 75 mg hyperbaric lidocaine 5% (n = 100) or 12 mg hyperbaric bupivacaine 0.75% (n = 100). Spinal anesthesia was administered to all patients in the sitting position with a 25-gauge Whitacre needle. The level of sensory blockade, time to full recovery, and intraoperative hemodynamic profile were noted in all patients. The patients were interviewed postoperatively for three consecutive days to detect the occurrence of TNS. The incidence of TNS was zero (95% confidence interval 0%3%) in both the Lidocaine and the Bupivacaine Groups. Our results indicate that the frequency of postoperative TNS does not exceed 3% in patients undergoing cesarean delivery at term using hyperbaric lidocaine 5% or hyperbaric bupivacaine 0.75%.
Implications: Transient neurologic symptom (TNS) can follow spinal anesthesia and manifests as back pain radiating to the legs, resolving spontaneously. Spinal anesthesia for cesarean delivery was performed with either hyperbaric lidocaine 5% (n = 100) or hyperbaric bupivacaine 0.75% (n = 100). TNS was not noted in any patient.
This article has been cited by other articles:
![]() |
J. T. YaDeau, G. A. Liguori, and V. M. Zayas The Incidence of Transient Neurologic Symptoms After Spinal Anesthesia with Mepivacaine Anesth. Analg., September 1, 2005; 101(3): 661 - 665. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Zaric, C. Christiansen, N. L. Pace, and Y. Punjasawadwong Transient Neurologic Symptoms After Spinal Anesthesia with Lidocaine Versus Other Local Anesthetics: A Systematic Review of Randomized, Controlled Trials Anesth. Analg., June 1, 2005; 100(6): 1811 - 1816. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Fassoulaki, V. Gatzou, G. Petropoulos, and I. Siafaka Spread of subarachnoid block, intraoperative local anaesthetic requirements and postoperative analgesic requirements in Caesarean section and total abdominal hysterectomy Br. J. Anaesth., November 1, 2004; 93(5): 678 - 682. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Meininger, C. Byhahn, P. Kessler, J. Nordmeyer, Y. Alparslan, B. A. Hall, and D. H. Bremerich Intrathecal Fentanyl, Sufentanil, or Placebo Combined with Hyperbaric Mepivacaine 2% for Parturients Undergoing Elective Cesarean Delivery Anesth. Analg., March 1, 2003; 96(3): 852 - 858. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Buckenmaier III, K. C. Nielsen, R. Pietrobon, S. M. Klein, A. H. Martin, R. A. Greengrass, and S. M. Steele Small-Dose Intrathecal Lidocaine Versus Ropivacaine for Anorectal Surgery in an Ambulatory Setting Anesth. Analg., November 1, 2002; 95(5): 1253 - 1257. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Campbell, C. M. Riben, M. E. Rooney, L.-A. L. Crone, and R. W. Yip Intrathecal Morphine for Postpartum Tubal Ligation Postoperative Analgesia Anesth. Analg., October 1, 2001; 93(4): 1006 - 1011. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Schneider and D. J. Birnbach Lidocaine Neurotoxicity in the Obstetric Patient: Is the Water Safe? Anesth. Analg., February 1, 2001; 92(2): 287 - 290. [Full Text] [PDF] |
||||
|